Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization

Molecular Pharmacology

Volumn 69, Issue 4, 2006, Pages 1421-1432

  Zhao, Hui ^a   Loh, Horace H ^a   Law, P Y ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; ETORPHINE; FORSKOLIN; METHADONE; METHYL BETA CYCLODEXTRIN; MORPHINE; NALOXONE;

ARTICLE; CELL SURFACE; CELL TRANSPORT; DESENSITIZATION; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LIPID RAFT; PRIORITY JOURNAL;

ADENYLATE CYCLASE; ANIMALS; CYCLIC AMP; ENDOCYTOSIS; ENZYME ACTIVATION; LIPID METABOLISM; RATS; RECEPTORS, OPIOID, MU;

EID: 33645100069     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.020024     Document Type: Article

References (72)

1. Ahn S, Kim J, Lucaveche CL, Reedy MC, Luttrell LM, Lefkowitz RJ, and Daaka Y (2002) Src-dependent tyrosine phosphorylation regulates dynamin self-assembly and ligand-induced endocytosis of the epidermal growth factor receptor. J Biol Chem 277:26642-26651.
2. Alvarez V, Arttamangkul S, and Williams JT (2001) A RAVE about opioid withdrawal. Neuron 32:761-763.
3. sα. Mol Pharmacol 52:993-999.
4. sα subunit. J Pharmacol Exp Ther 286:855-862.
5. sα. J Biol Chem 271:21309-21315.
6. Avidor-Reiss T, Nevo I, Saya D, Bayerwitch M, and Vogel Z (1997) Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J Biol Chem 272:5040-5047.
7. Bari M, Battista N, Fezza F, Finazzi-Agro A, and Maccarrone M (2005) Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J Biol Chem 280:12212-12220.
8. Bohn LM, Dykstra LA, Lefkowitz RJ, Caron MG, and Barak LS (2004) Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery. Mol Pharmacol 66:106-112.
9. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, and Caron MG (2000) mu-Opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature (Lond) 408:720-723.
10. Chakrabarti S, Oppermann M, and Gintzler AR (2001) Chronic morphine induces the concomitant phosphorylation and altered association of multiple signaling proteins: a novel mechanism for modulating cell signaling. Proc Natl Acad Sci USA 98:4209-4214.
11. Chakrabarti S, Rivera M, Yan SZ., Tang WJ, and Gintzler AR (1998a) Chronic morphine augments G/Gs stimulation of adenylyl cyclase: relevance to opioid tolerance. Mol Pharmacol 54:655-662.
12. Chakrabarti S, Wang L, Tang W-J, and Gintzler AR (1998b) Chronic morphine augments adenylyl cyclase phosphorylation: relevance to altered signaling during tolerance/dependence. Mol Pharmacol 54:949-953.
13. Chavkin C, McLaughlin JP, and Celver JP (2001) Regulation of opioid receptor function by chronic agonist exposure: constitutive activity and desensitization. Mol Pharmacol 60:20-25.
14. Chu P, Murray S, Lissin D, and von Zastrow M (1997) δ and κ Opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. J Biol Chem 272:27124-27130.
15. Claude-Geppert P, Liu J, Solberg J, Erickson-Herbrandson LJ, Loh HH, and Law PY (2005) Antagonist efficacy in MORS196L mutant is affected by the interaction between transmembrane domains of the opioid receptor. J Pharmacol Exp Ther 313:216-226.
16. Crain SM and Shen KF (1996) Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance and dependence. Neurochem Res 21:1347-1351.
17. Cvejic S and Devi LA (1997) Dimerization of the κ opioid receptor: implication for a role in receptor internalization. J Biol Chem 272:26959-26964.
18. Dupree P, Parton RG, Raposo G, Kurzchalia TV, and Simons K (1993) Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO (Eur Mol Biol Organ) J 12:1597-1605.
19. 5-ol]enkephalin inhibition of adenylyl cyclase activity and agonist-induced μ-opioid receptor phosphorylation. J Biol Chem 274:9207-9215.
20. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, and Michel T (1996) Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 271:22810-22814.
21. Feron O, Smith TW, Michel T, and Kelly RA (1997) Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J Biol Chem 272:17744-17748.
22. Finn AK and Whistler JL (2001) Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron 32:829-839.
23. Haberstock-Debic H, Kim KA, Yu YJ, and von Zastrow M (2005) Morphine promotes rapid, arrestin-dependent endocytosis of mu-opioid receptors in striatal neurons. J Neurosci 25:7847-7857.
24. Haberstock-Debic H, Wein M, Barrot M, Colago EE, Rahman Z, Neve RL, Pickel VM, Nestler EJ, von Zastrow M, and Svingos AL (2003) Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons. J Neurosci 23:4324-4332.
25. Harder T and Engelhardt KR (2004) Membrane domains in lymphocytes - from lipid rafts to protein scaffolds. Traffic 5:265-275.
26. He L, Fong J, von Zastrow M, and Whistler JL (2002) Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108:271-282.
27. Jiao X, Zhang N, Xu X, Oppenheim JJ, and Jin T (2005) Ligand-induced partitioning of human CXCR1 chemokine receptors with lipid raft microenvironments facilitates G-protein-dependent signaling. Mol Cell Biol 25:5752-5762.
28. Keith DE, Anton B, Murray SR, Zaki PA, Chu PC, Lissin DV, Monteillet-Agius G, Stewart PL, Evans CJ, and von Zastrow M (1998) mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol Pharmacol 53:377-384.
29. Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, Kang L, Evans CJ, and von Zastrow M (1996) Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 271:19021-19024.
30. Kieffer BL and Evans CJ (2002) Opioid tolerance-in search of the holy grail. Cell 108:587-590.
31. Kreek MJ (2000) Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann NY Acad Sci 909:186-216.
32. Law P-Y, Erickson-Herbrandson LJ, Zha QQ, Solberg J, Chu J, Sarre A, and Loh HH (2005) Heterodimerization of μ- and δ-opioid receptors occurs at cell surface only and requires receptor-G protein interactions. J Biol Chem 280:11152-11164.
33. Law P-Y, Hom DS, and Loh HH (1982) Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment: a multiple step process. Mol Pharmacol 22:1-4.
34. Law P-Y, Hom D, and Loh HH (1983) Opiate receptor down-regulation and desensitization in neuroblastoma x glioma NG108-15 hybrid cells are two separate cellular adaption processes. Mol Pharmacol 24:413-424.
35. Law P-Y, Kouhen OM, Solberg J, Wang W, Erickson LJ, and Loh HH (2000) Deltorphin II-induced rapid desensitization of δ-opioid receptor requires both phosphorylation and internalization of the receptor. J Biol Chem 275:32057-32065.
36. Law P-Y, McGinn T, Wick M, Erickson L, Evans C, and Loh H (1994) Analysis of δ-opioid receptor activities stably expressed in CHO cell lines: function of receptor density. J Pharmacol Exp Ther 271:1686-1694.
37. Lee H, Park DS, Wang XB, Scherer PE, Schwartz PE, and Lisanti MP (2002) Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-caveolin-2 (Tyr(P)19) is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1. J Biol Chem 277:34556-34567.
38. Li JG, Luo LY, Krupnick JG, Benovic JL, and Liu-Chen LY (1999) U50,488H-induced internalization of the human κ opioid receptor involves a β-arrestin- and dynamin-dependent mechanism. κ Receptor internalization is not required for mitogen-activated protein kinase activation. J Biol Chem 274:12087-12094.
39. Li S, Couet J, and Lisanti MP (1996a) Src tyrosine kinases, Gα subunits and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271:29182-29190.
40. Li S, Song KS, and Lisanti MP (1996b) Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes. J Biol Chem 271:568-573.
41. Lisanti MP, Scherer PE, Vidugiriene J, Tang ZL, Hermanoski-Vosatka A, Tu YH, Cook RF, and Sargiacomo M (1994) Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 126:111-126.
42. 5]enkephalin. J Biol Chem 276:37779-37786.
43. Lowry O, Rosebrough N, Farr A, and Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
44. Luttrell LM, Della Rocca GJ, van Biesen T, Luttrell DK, and Lefkowitz RJ (1997) Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J Biol Chem 272:4637-4644.
45. Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, et al. (1999) beta-Arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science (Wash DC) 283:655-661.
46. Luttrell LM, Hawes BE, van Biesen T, Luttrell DK, Lansing TJ, and Lefkowitz RJ (1996) Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gβγ subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem 271:19443-19450.
47. Marwali MR, Rey-Ladino J, Dreolini L, Shaw D, and Takei F (2003) Membrane cholesterol regulates LFA-1 function and lipid raft heterogeneity. Blood 102:215-222.
48. Mineo C, Ying YS, Chapline C, Jaken S, and Anderson RG (1998) Targeting of protein kinase Cα to caveolae. J Cell Biol 141:601-610.
49. Monastyrskaya K, Hostettler A, Buergi S, and Draeger A (2005) The NK1 receptor localizes to the plasma membrane microdomains and its activation is dependent on lipid raft integrity. J Biol Chem 280:7135-7146.
50. Nabi IR and Le PU (2003) Caeolae/raft-dependent endocytosis. J Cell Biol 161:673-677.
51. Nguyen DH, Giri B, Collins G, and Taub DD (2005) Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts and adhesion molecules to sites of CD4 engagement. Exp Cell Res 304:559-569.
52. Ostrom RS, Gregriam C, Drenan RM, Xiang Y, Regan JW, and Insel PA (2001) Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase. J Biol Chem 276:42063-42069.
53. Quinton TM, Kim S, Jin J, and Kunapuli SP (2005) Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation. J Throm Haemost 3:1036-1041.
54. Razani B and Lisanti MP (2001) Two distinct caveolin-1 domains mediate the functional interaction of caveolin-1 with protein kinase A. Am J Physiol 281:C1241-C1250.
55. Sargiacomo M, Sudol M, Tang Z, and Lisanti MP (1993) Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 122:789-807.
56. Schwencke C, Yamamoto M, Okumura S, Toya Y, Kim SJ, and Ishikawa Y (1999) Compartmentation of cyclic adenosine 3′,5′-monophosphate signaling in caveolae. Mol Endocrinol 13:1061-1070.
57. Sharma SK, Klee WA, and Nirenberg M (1977) Opiate dependent modulation of adenylate cyclase activity. Proc Natl Acad Sci USA 74:3365-3369.
58. Sharma SK, Nirenberg M, and Klee W (1975) Morphine receptors as regulators of adenylate cyclase activity. Proc Natl Acad Sci USA 72:590-594.
59. Smart EJ, Foster DC, Ying YS, Kamen BA, and Anderson RG (1994) Protein kinase C activators inhibit receptor-mediated potocytosis by preventing internalization of caveolae. J Cell Biol 124:307-313.
60. Smart EJ, Ying YS, and Anderson RG (1995) Hormonal regulation of caveolae internalization. J Cell Biol 131:929-938.
61. Sotgia F, Razani B, Bonuccelli G, Schubert W, Battista M, Lee H, Capozza F, Schubert AL, Minetti C, Buckley JT, et al. (2002) Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells. Mol Cell Biol 22:3905-3926.
62. Taylor DA and Fleming WW (2001) Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J Pharmacol Exp Ther 297:11-18.
63. Triantafilou M, Miyake K, Colenbock DT, and Triantafilou K (2002) Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 115:2603-2611.
64. Tso PH and Wong YH (2001) Opioid-induced adenylyl cyclase supersensitization in human embryonic kidney 293 cells requires pertussis toxin-sensitive G proteins other than G(i1) and G(i3). Neurosci Lett 299:25-28.
65. Varga EV, Rubenzik MK, Stropova D, Sugiyama M, Grife V, Hruby VJ, Rice KC, Roeske WR, and Yamamura HI (2003a) Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic δ-opioid agonist treatment. J Pharmacol Exp Ther 306:109-115.
66. Varga EV, Stropova D, Rubenzik M, Waite S, Roeske WR, and Yamamura HI (1999) Phosphorylation of adenylyl cyclase VI on chronic d-opioid receptor stimulation. Eur J Pharmacol 364:R1-R3.
67. Varga EV, Yamamura HI, Rubenzik MK, Stropova D, Navratilova E, and Roeske WR (2003b) Molecular mechanisms of excitatory signaling upon chronic opioid agonist treatment. Life Sci 74:299-311.
68. Whistler JL, Chuang HH, Chu P, Jan LY, and von Zastrow M (1999) Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23:737-746.
69. Whistler JL and von Zastrow M (1998) Morphine-activated opioid receptors elude desensitization by beta-arrestin. Proc Natl Acad Sci USA 95:9914-9919.
70. Whistler JL and von Zastrow M (1999) Dissociation of functional roles of dynamin in receptor-mediated endocytosis and mitogenic signal transduction. J Biol Chem 274:24575-24578.
71. Xue M, Vines CM, Buranda T, Cimino DF, Bennett TA, and Prossnitz ER (2004) N-Formyl peptide receptors cluster in an active raft-associated state prior to phosphorylation. J Biol Chem 279:45175-45184.
72. Zhang J, Ferguson SS, Barak LS, Menard L, and Caron MG (1996) Dynamin and β-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization. J Biol Chem 271:18302-18305.